USPTO 2015–2025 USPTO PatentsView US Corporation

Genomatica, Inc.

USPTO PatentsView assignee record - 155 granted patents across 29 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

155
Total patents granted
29
CPC technology areas
17.0
Avg claims per patent
+35%
5-year filing velocity

The verdict

Genomatica holds 155 US patents across 29 technology areas, rank #2,513 of 50,000 tracked assignees.

#2,513
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.5/100)
17.0
avg claims per patent
+35%
filing velocity, last 5 yrs

Portfolio overview

Genomatica, Inc. has been granted 155 US utility patents between 2015 and 2025, placing Genomatica, Inc. at rank #2,513 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a US Corporation, Genomatica, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Genomatica sits between Access Business Group International Llc (155 patents, rank #2,509) and ONO Pharmaceutical Co., Ltd. (155 patents, rank #2,517) - the closest US assignees by grant volume. The composite Innovation Score of 51.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 89 grants, compared with 66 in the 2015–2019 window, a +35% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Genomatica, Inc.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Genomatica, Inc. against peers pursuing similar technology classes.

Who files at Genomatica's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Genomatica holds 155 patents at rank #2,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Genomatica

By rank, the assignees closest to #2,513 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Genomatica's primary technology class.

Genomatica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

510152025 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Genomatica, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 15 9.7%
2016 10 6.5%
2017 10 6.5%
2018 17 11.0%
2019 14 9.0%
2020 20 12.9%
2021 20 12.9%
2022 17 11.0%
2023 13 8.4%
2024 9 5.8%
2025 10 6.5%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#2,513

Across all tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Genomatica, Inc. hold?
Genomatica, Inc. holds 155 US granted patents filed between 2015 and 2025, spanning 29 technology areas.
What is Genomatica, Inc.'s Innovation Score?
Genomatica, Inc. has an Innovation Score of 51.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Genomatica, Inc. focus on?
Genomatica, Inc.'s top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 145 patents. The company has filed patents in 29 CPC subclasses total.
Is Genomatica, Inc.'s patent filing rate increasing or decreasing?
Genomatica, Inc.'s recent filing velocity is +35% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Genomatica, Inc.'s patents?
Genomatica, Inc.'s patents average 17.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Genomatica, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Genomatica's 155 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Genomatica ranks #2,513 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12P - see who else leads that technology area. C12P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.